| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 16 |
| 1 | METHOTREXATE | 6 |
| 2 | METHOTREXATE SODIUM | 6 |
| 3 | ATORVASTATIN CALCIUM | 5 |
| 4 | BEVACIZUMAB | 5 |
| 5 | LORAZEPAM | 5 |
| 6 | ACETAMINOPHEN | 4 |
| 7 | AMISULPRIDE | 4 |
| 8 | AMLODIPINE | 4 |
| 9 | CELECOXIB | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SENNOSIDES, DOCUSATE SODIUM | 1 | 0.0250 |
| 1 | LAROTRECTINIB | 1 | 0.0011 |
| 2 | CLOMIPRAMINE HYDROCHLORIDE | 3 | 0.0007 |
| 3 | AMISULPRIDE | 4 | 0.0007 |
| 4 | ALGLUCOSIDASE ALFA | 1 | 0.0004 |
| 5 | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 2 | 0.0002 |
| 6 | SALINE NASAL SPRAY | 1 | 0.0002 |
| 7 | TREMELIMUMAB | 1 | 0.0002 |
| 8 | GEFITINIB | 2 | 0.0002 |
| 9 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 4 | 0.0005 |
| 1 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 2 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 5 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 7 | Alkaloid [EPC] | 2 | 0.0001 |
| 8 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |